Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating substantial results in the management of type 2 diabetes. This synthetic peptide duplicates the actions of naturally present GLP-1, a hormone that plays a crucial role in controlling blood sugar concentrations. By stimulating GLP-1 receptors in the pancreas, Retasturtid